Yizhou Dong, Ph.D

Yizhou Dong is a Professor at the Icahn School of Medicine at Mount Sinai. His research focuses on the design and development of biotechnology platforms for the treatment of genetic disorders, infectious diseases, and cancer. Dr. Dong has authored over one hundred papers and patents. Over seventy of his patents have been licensed by biotech companies and are currently under development as drug candidates for clinical trials. He serves as a scientific advisory board member for Arbor Biotechnologies and Sirnagen Therapeutics. Dr. Dong is the recipient of multiple awards, such as Maximizing Investigators’ Research Award from the National Institute of General Medical Sciences (NIGMS) and The American Association of Pharmaceutical Scientists (AAPS) Emerging Leader Award. Dr. Dong is an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE) and also an elected fellow of the National Academy of Inventors.